Reuters: Regulatory News: UPDATE 1-Alere starts recall of cardiology test lots

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Alere starts recall of cardiology test lots May 23rd 2012, 16:31 Wed May 23, 2012 12:31pm EDT May 23 (Reuters) - Diagnostic device maker Alere Inc said it started a recall of about 104 lots of its Triage cardiology products as they do not satisfy a particular quality control method as prescribed by U.S. health regulators, sending its shares down as much as 4 percent. The company earlier this month warned of a need to recall after the U.S. Food and Drug Administration inspected its San Diego facility in March and questioned labeling and quality control method of its Triage products. Alere expects to have limited inventory of its Triage cardiology panels for an unknown duration of time, but said it was "significantly increasing production" and sees a related increase in manufacturing costs from the second quarter of 2012. The recall covers unexpired lots of Alere Triage cardiology products sold in the United States, but allows customers who do not have an alternate testing method to continue using these lots. Alere shares, which have lost 19 percent of their value since the company warned of the recall, were trading down 3 percent at $18.12 on Wednesday on the New York Stock Exchange.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions